Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-β/δ antagonist GSK3787
…, CR Anderson, GH Perdew, FJ Gonzalez, R Müller… - Molecular …, 2010 - ASPET
The availability of high-affinity agonists for peroxisome proliferator-activated receptor-β/δ (PPARβ/δ)
has led to significant advances in our understanding of the functional role of PPARβ/…
has led to significant advances in our understanding of the functional role of PPARβ/…
[HTML][HTML] CD8+ T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ
…, FJ Horvath, MA Podolsky, CR Anderson… - Journal of Investigative …, 2013 - Elsevier
The RAS signaling pathway is constitutively activated in psoriatic keratinocytes. We expressed
activated H-RAS V12G in suprabasal keratinocytes of adult mice and observed rapid …
activated H-RAS V12G in suprabasal keratinocytes of adult mice and observed rapid …
Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α
…, DJ Ehresman, JL Butenhoff, CR Anderson… - Toxicological …, 2009 - academic.oup.com
Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …
Effect of prenatal peroxisome proliferator-activated receptor α (PPARα) agonism on postnatal development
PS Palkar, CR Anderson, CH Ferry, FJ Gonzalez… - Toxicology, 2010 - Elsevier
Recent work indicates that PPARα is required for perfluorooctanoic acid (PFOA)-induced
postnatal lethality resulting from prenatal exposure. The present study tested the hypothesis …
postnatal lethality resulting from prenatal exposure. The present study tested the hypothesis …
[HTML][HTML] Cholestasis induces reversible accumulation of periplakin in mouse liver
…, T Matsubara, YM Shah, S Ahn, CR Anderson… - BMC …, 2013 - Springer
Background Periplakin (PPL) is a rod-shaped cytolinker protein thought to connect cellular
adhesion junctional complexes to cytoskeletal filaments. PPL serves as a structural …
adhesion junctional complexes to cytoskeletal filaments. PPL serves as a structural …
[PDF][PDF] Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps
B Chen, S Cherie'R, ET McKinley, AJ Simmons… - Cell, 2021 - cell.com
Colorectal cancers (CRCs) arise from precursor polyps whose cellular origins, molecular
heterogeneity, and immunogenic potential may reveal diagnostic and therapeutic insights …
heterogeneity, and immunogenic potential may reveal diagnostic and therapeutic insights …
[PDF][PDF] Differential hepatic effects of perfluorobutyrate (PFBA) mediated by mouse and human PPARα
…, SC Chang, DJ Ehresman, JL Butenhoff, CR Anderson… - Citeseer
Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …
similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, …
[HTML][HTML] The cell cycle inhibitor p21waf1 binds to the myc and cdc25A promoters upon DNA damage and induces transcriptional repression
A Vigneron, J Cherier, B Barré, E Gamelin… - Journal of Biological …, 2006 - ASBMB
In addition to its function as a cyclin-dependent kinase (cdk) inhibitor, p21 waf1 fulfills
additional roles involved in DNA replication and transcriptional regulation that could also …
additional roles involved in DNA replication and transcriptional regulation that could also …
Minimization of indoor temperatures and total solar insolation by optimizing the building orientation in hot climate
In order to reduce the energy load, understanding the overall architectural design features
and optimizing building orientation are important. They are guided by natural elements like …
and optimizing building orientation are important. They are guided by natural elements like …
[HTML][HTML] The c-Jun/RHOB/AKT pathway confers resistance of BRAF-mutant melanoma cells to MAPK inhibitors
A Delmas, J Cherier, M Pohorecka… - Oncotarget, 2015 - ncbi.nlm.nih.gov
The response of BRAF-mutant melanoma patients to BRAF inhibitors is dramatically impaired
by secondary resistances and rapid relapse. So far, the molecular mechanisms driving …
by secondary resistances and rapid relapse. So far, the molecular mechanisms driving …